February 12, 2026

FDA Approves HRT Label Changes

The agency cited updated evidence in revising hormone therapy safety language.

Conexiant

February 12, 2026

Abortion and Breast Cancer: Any Link?

Analysis of more than 30,000 breast cancer cases finds no increased risk of breast cancer following induced abortion or miscarriage

Conexiant

February 12, 2026

Ultrasound by Robot: The Debate

State proposes telerobotic scans to address rural gaps.

KFF Health News

February 11, 2026

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

Conexiant

February 11, 2026

Universal Aspirin in High-Risk Pregnancies?

Direct dispensation at first prenatal visit delays onset, reduces rates in high-risk population without increasing hemorrhage.

Conexiant

February 04, 2026

FDA Expands HPV Primary Screening Options

Regulatory action broadens available approaches for cervical cancer screening in US clinical practice.

Conexiant

February 04, 2026

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

KFF Health News

February 03, 2026

When Hemoglobin Signals Neonatal Risk

Study finds both low and high early pregnancy values linked to adverse outcomes

Conexiant

February 02, 2026

Rethinking Prehabilitation Before Surgery

Researchers compare personalized versus standard prehabilitation and examine functional, immune, and postoperative outcomes before major elective surgery.

Conexiant